Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12903-12911

  Matsui, Chieko ^a   Shoji, Ikuo ^a   Kaneda, Shusaku ^a   Sianipar, Imelda Rosalyn ^a,b   Deng, Lin ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 2; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; NONSTRUCTURAL PROTEIN 5A; PROTEASOME INHIBITOR; PROTEINASE INHIBITOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE REPRESSION; GLUCOSE TRANSPORTER 2 GENE; HEPATITIS C; HEPATOCYTE NUCLEAR FACTOR 1ALPHA GENE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REPLICON; TRANSCRIPTION REGULATION; VIRUS INFECTIVITY;

ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; HEPATITIS C; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUCIFERASES; LYSOSOMES; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEOLYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84869233925     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01418-12     Document Type: Article

References (40)

1. Armendariz AD, Krauss RM. 2009. Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr. Opin. Lipidol. 20:106-111.
2. Ban N, et al. 2002. Hepatocyte nuclear factor-1α recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 51:1409-1418.
3. Blight KJ, Kolykhalov AA, Rice CM. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
4. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76: 13001-13014.
5. Bluteau O, et al. 2002. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet. 32:312-315.
6. Bungyoku Y, et al. 2009. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J. Gen. Virol. 90:1681-1691.
7. Cha JY, Kim H, Kim KS, Hur MW, Ahn Y. 2000. Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1α and 3α. J. Biol. Chem. 275:18358-18365.
8. Denamur S, et al. 2011. Role of oxidative stress in lysosomal membrane permeabilization and apoptosis induced by gentamicin, an aminoglycoside antibiotic. Free Radic. Biol. Med. 51:1656-1665.
9. Deng L, et al. 2008. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J. Virol. 82:10375-10385.
10. Deng L, et al. 2006. NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequencedependent manner. J. Gen. Virol. 87:1703-1713.
11. Deng L, et al. 2011. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J. Virol. 85:8556-8568.
12. Dice JF. 2007. Chaperone-mediated autophagy. Autophagy 3:295-299.
13. Dionisio N, et al. 2009. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J. Hepatol. 50:872-882.
14. Dreux M, Chisari FV. 2011. Impact of the autophagy machinery on hepatitis C virus infection. Viruses 3:1342-1357.
15. Griffin S, Clarke D, McCormick C, Rowlands D, Harris M. 2005. Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. J. Virol. 79:15525-15536.
16. He Y, Staschke KA, Tan SL. 2006. HCV NS5A: a multifunctional regulator of cellular pathways and virus replication. In Tan SL (ed), HepatitisC viruses: genomes and molecular biology. Horizon Bioscience, Norfolk, United Kingdom. http://www.ncbi.nlm.nih.gov/books/NBK1621/.
17. Ikeda M, et al. 2005. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem. Biophys. Res. Commun. 329:1350-1359.
18. Inubushi S, et al. 2008. Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk. J. Gen. Virol. 89:1231-1242.
19. Kasai D, et al. 2009. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J. Hepatol. 50:883-894.
20. Lee YH, Sauer B, Gonzalez FJ. 1998. Laron dwarfism and non-insulindependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell Biol. 18:3059-3068.
21. Lemon SM, Walker C, Alter MJ, Yi M. 2007. Hepatitis C virus, p 1291-1304. In Knipe DM, et al (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
22. Li ZY, Yang Y, Ming M, Liu B. 2011. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414:5-8.
23. Lindenbach BD, et al. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
24. Macheda ML, Rogers S, Best JD. 2005. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell Physiol. 202: 654-662.
25. Malecki MT, Mlynarski W. 2008. Monogenic diabetes: implications for therapy of rare types of disease. Diabetes Obes. Metab. 10:607-616.
26. Mason AL, et al. 1999. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29:328-333.
27. Murakami K, et al. 2006. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genomelength dicistronic viral RNA of genotype 1b. Virology 351:381-392.
28. Nakashima K, Takeuchi K, Chihara K, Hotta H, Sada K. 2011. Inhibition of hepatitis C virus replication through adenosine monophosphateactivated protein kinase-dependent and -independent pathways. Microbiol. Immunol. 55:774-782.
29. Negro F. 2011. Mechanisms of hepatitis C virus-related insulin resistance. Clin. Res. Hepatol Gastroenterol. 35:358-363.
30. Negro F, Alaei M. 2009. Hepatitis C virus and type 2 diabetes. World J. Gastroenterol. 15:1537-1547.
31. Pontoglio M, et al. 1996. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84:575-585.
32. Qadri I, et al. 2004. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitisCvirus replication: role of JNK, p38 MAPK and AP-1. Biochem. J. 378:919-928.
33. Shirakura M, et al. 2007. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J. Virol. 81:1174-1185.
34. Takeda J, Kayano T, Fukomoto H, Bell GI. 1993. Organization of the human GLUT2 (pancreatic beta-cell and hepatocyte) glucose transporter gene. Diabetes 42:773-777.
35. Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM. 2004. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J. Biol. Chem. 279:48576-48587.
36. Tellinghuisen TL, Marcotrigiano J, Rice CM. 2005. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435:374-379.
37. Wakita T, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
38. Wang AG, et al. 2009. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J. Pathol. 219:253-262.
39. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB. 1998. Dominantnegative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line. EMBO J. 17:6701-6713.
40. Yamagata K, et al. 1996. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458.